Skip to main content
. 2014 Nov 14;2(4):327–344. doi: 10.3390/biomedicines2040327

Figure 2.

Figure 2

Expression of Met in different MM (Malignant mesothelioma) cell lines. Immunoprecipitation with Met antibodies, followed by immunoblotting with the same antibodies. Asterisks on the right indicate the Met precursor (pr170MET, **) and the mature β-chain (p145MET, *). GTL16 are gastric carcinoma cells bearing Met amplification and overexpression (control). Modified from [43].